M/21/078 – Triton Group(Triley Bidco)/Clinigen
The proposed acquisition by Triley Bidco Limited, which is indirectly controlled by funds managed or advised by Triton Fund V L.P, of sole control of Clinigen Group plc has been cleared by the Competition and Consumer Protection Commission.
|Notification date||Decision date|
|Thursday December 23, 2021||Tuesday, January 11, 2022|
|Parties Involved||Business activities|
Triton Group is a privately-held investment firm that manages a number of independent investment funds and companies.
|Clinigen Group plc||
Clinigen is a global pharmaceutical services and products company focused on providing ethical access to medicines.
|Economic sector||Media merger|
|Submissions from third parties due by:|
|Phase 1||Phase 2|
|Wednesday, January 5, 2022|
|Current status: Completed|
|Simplified Merger Notification|
|Authorised Officer Assigned||Contact Details|
Media enquiries: email@example.com